Afghanistan vs Hong Kong, China: Treatment success rate for patients treated for MDR-TB
Afghanistan
72.0%
in 2022
Hong Kong, China
72.0%
in 2022
Afghanistan rank
87th
Hong Kong, China rank
87th
Treatment success rate for patients treated for MDR-TB over time
- Afghanistan
- Hong Kong, China
How they compare
Afghanistan currently reports 72.0% against 72.0% in Hong Kong, China, a difference of 0.0%.
The two have swapped places 3 times across 12 shared years of data; in 2011 it was Afghanistan ahead.
Afghanistan ranks 87th and Hong Kong, China ranks 87th of 163 countries.
Hong Kong, China has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Hong Kong, China | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.2% | 71.2% | 5.0% | Hong Kong, China |
| 2020s | 71.3% | 80.0% | 8.7% | Hong Kong, China |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Afghanistan or Hong Kong, China?
- Afghanistan, at 72.0% against 72.0% in Hong Kong, China as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Afghanistan and Hong Kong, China?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Hong Kong, China?
- 12 years are reported by both, from 2011 to 2022.
- How do Afghanistan and Hong Kong, China rank globally for treatment success rate for patients treated for mdr-tb?
- Afghanistan ranks 87th and Hong Kong, China ranks 87th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.